AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 NOV 12 - (NewsRx.com & NewsRx.net) -- IDM (Immuno-Designed Molecules), a biopharmaceutical company specializing in the field of cellular immunotherapy, announced that it will coordinate a European research project entitled "Dendritophages, therapeutic cellular vaccines," financed by the European Union for EUR2 million.
This project includes five other partners: The Children's Cancer Research Institute (Austria), Etna Biotech (Italy), The Istituto Superiore di Sanita (Italy), the Peter McCallum Cancer Institute (Australia), and the University of Regensburg (Germany).
The objectives of this project are the optimization of cellular vaccines developed from dendritic cells, the definition of their fabrication process on an industrial scale, and the clinical development of a vaccine against ...